| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| G MEDICAL INNOVATIONS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 7,674 | +4,32 % | Teladoc Health, Inc.: Teladoc Health Reports First Quarter 2026 Results | NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 ("First... ► Artikel lesen | |
| HIMS & HERS HEALTH | 29,560 | -0,67 % | Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know | ||
| BICO GROUP | 1,474 | +1,66 % | -17,58% Rückgang bei BICO: Analyse der Preisveränderung | ||
| GERATHERM MEDICAL | 2,650 | -2,57 % | Geratherm Medical AG: Ein herausforderndes GJ26 folgt auf ein schwieriges GJ25; Kursziel gesenkt, KAUFEN. | Geratherm hat die Ergebnisse für das Geschäftsjahr 2025 veröffentlicht. Die Umsätze stiegen um 6 %, jedoch führten erhebliche makroökonomische Gegenwinde, Wettbewerb aus China und inländischer Kostendruck... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,013 | -5,71 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| PLUS THERAPEUTICS | 3,650 | 0,00 % | Plus Therapeutics wins Elevance Health coverage deal | ||
| HEALWELL AI | 0,476 | -2,66 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| INVITAE | - | - | Patentstreit: Natera sichert sich 30 % Lizenzgebühr von Invitae | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results | Revenues increased 48% in Q4 2026 compared to Q4 2025, and 37% in FY 2026 compared to FY 2025United States revenues increased 194% in Q4 2026 compared to Q4 2025 and 117% in FY 2026 compared to FY 2025Net... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| EMEIS | 13,800 | -3,90 % | emeis 2026 General Meeting | Summary of voting results Olivier Dussopt appointed as Chairman of the Board of Directors Laurent Guillot re-elected as a director and confirmed in his Chief Executive Officer role
Regulatory... ► Artikel lesen | |
| CYTOSORBENTS | 0,330 | -5,71 % | Cytosorbents Corp - 8-K, Current Report | ||
| SENSEONICS | 5,200 | +2,97 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,080 | 0,00 % | Tempest Therapeutics, Inc. - 8-K, Current Report | ||
| PANGENOMIC HEALTH | 0,205 | -5,53 % | XFRA LL3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |